These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35759613)

  • 21. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 22. The economics of improving medication adherence in osteoporosis: validation and application of a simulation model.
    Patrick AR; Schousboe JT; Losina E; Solomon DH
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2762-70. PubMed ID: 21733991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic implications of non-adherence after renal transplantation.
    Cleemput I; Kesteloot K; Vanrenterghem Y; De Geest S
    Pharmacoeconomics; 2004; 22(18):1217-34. PubMed ID: 15606228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Impact of Sample Medication on Subsequent Patient Adherence.
    Pringle JL; Aldridge A; Kearney SM; Grasso K; Radack J; Hogue S; Manolis C
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1262-1269. PubMed ID: 27783544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
    Muduma G; Odeyemi I; Pollock RF
    J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addressing Medication Costs During Primary Care Visits: A Before-After Study of Team-Based Training.
    Carroll JK; Farah S; Fortuna RJ; Lanigan AM; Sanders M; Venci JV; Fiscella K
    Ann Intern Med; 2019 May; 170(9_Suppl):S46-S53. PubMed ID: 31060055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.
    Henderson C; Knapp M; Yeeles K; Bremner S; Eldridge S; David AS; O'Connell N; Burns T; Priebe S
    PLoS One; 2015; 10(10):e0138816. PubMed ID: 26448540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoting Medication Adherence Among Psychiatric Patients With a History of Nonadherence: A Clinical Practice Improvement Program.
    Xia XS; Poremski D; Ubana RL; Ravichandran N
    J Psychiatr Pract; 2020 Jul; 26(4):284-293. PubMed ID: 32692125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 32. A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans.
    Chinthammit C; Axon DR; Anderson S; Lott B; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Clin Lipidol; 2020; 14(6):791-798. PubMed ID: 33011136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence.
    Plumpton CO; Brown I; Reuber M; Marson AG; Hughes DA
    Epilepsy Behav; 2015 Apr; 45():180-6. PubMed ID: 25819948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SystemCHANGE™ Solutions to Improve Medication Adherence in Kidney Transplant Recipients: A Secondary Data Analysis.
    Andrews AM; Cheng AL; Bartlett Ellis RJ; Emerson AM; O'Brien T; Russell CL
    Nephrol Nurs J; 2021; 48(4):389-417. PubMed ID: 34463466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Res Notes; 2018 Sep; 11(1):655. PubMed ID: 30201054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a Pharmacist-Led Web-Based Medication Adherence Tool With Patient-Centered Communication: Results of a Clustered Randomized Controlled Trial.
    van Lieshout J; Lacroix J; van Halteren A; Teichert M
    J Med Internet Res; 2022 Apr; 24(4):e16141. PubMed ID: 35389359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in medication adherence between preemptive and post-dialysis young kidney transplant recipients.
    Vaisbourd Y; Dahhou M; De Simone A; Zhang X; Foster BJ
    Pediatr Nephrol; 2023 Jun; 38(6):1949-1956. PubMed ID: 36357639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic impact of medication non-adherence by disease groups: a systematic review.
    Cutler RL; Fernandez-Llimos F; Frommer M; Benrimoj C; Garcia-Cardenas V
    BMJ Open; 2018 Jan; 8(1):e016982. PubMed ID: 29358417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.